HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew G Oser Selected Research

Matthew G Oser Research Topics

Disease

10Neoplasms (Cancer)
01/2024 - 12/2015
4Lung Neoplasms (Lung Cancer)
01/2024 - 12/2019
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 12/2019
1Bites and Stings (Sting)
01/2022
1Multiple Myeloma
01/2021
1Genomic Instability
01/2020
1Carcinogenesis
12/2019
1Melanoma (Melanoma, Malignant)
12/2015
1Retinoblastoma (Glioblastoma, Retinal)
12/2015
1Dermatitis
07/2014

Drug/Important Bio-Agent (IBA)

3Histone DemethylasesIBA
01/2022 - 01/2018
2Transcription Factors (Transcription Factor)IBA
01/2024 - 01/2021
2InterferonsIBA
11/2023 - 01/2022
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2020
1Adenosine Triphosphatases (ATPase)IBA
01/2024
1B7-H1 AntigenIBA
11/2023
1Aurora Kinase AIBA
11/2023
1Circulating Tumor DNAIBA
11/2023
1Immunomodulating AgentsIBA
01/2021
1Thalidomide (Thalomid)FDA Link
01/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2021
1YKL-5-124IBA
01/2020
1Cre recombinaseIBA
12/2019
1E2F Transcription FactorsIBA
12/2019
1Retinoblastoma ProteinIBA
12/2019
1Glutathione (Reduced Glutathione)IBA
01/2019
1AntioxidantsIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Aurora Kinase BIBA
01/2019
1Deubiquitinating EnzymesIBA
01/2019
1palbociclibIBA
01/2019
1AntigensIBA
12/2015
1Proteins (Proteins, Gene)FDA Link
12/2015
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
12/2015
1CrizotinibIBA
07/2014

Therapy/Procedure

2Immunotherapy
01/2024 - 11/2023
1Therapeutics
01/2019